06
Life Sciences
AI adoption under regulated constraints · Governance integrated into the path to scale
III. Sectors · 06
06
AI adoption under regulated constraints · Governance integrated into the path to scale
Support activities
Primary activities
In Biopharma and MedTech, every decision carries a responsibility that extends beyond business: trust, quality, and continuity of patient care.
Across regional operations, where value lies in ensuring the right product reaches the right patient, Artificial Intelligence delivers impact across four key areas:
The result is a stronger, more enduring relationship between the life sciences industry and healthcare professionals, supported by reliable operations when patients need them most.

Unimed
Grupo Boticário · GAVB · 2022
ChallengeAdd-on and upgrade offers were not reaching the right customer at the right time.
SolutionPersonalized recommendation, with hyper-personalized campaigns and proactive outreach to the right audience.

Unimed
Grupo Boticário · GAVB · 2023
ChallengeA high volume of medical audit requests hid abuse and fraud in high-cost procedures.
SolutionDenial probability at pre-audit: low-value requests approved or denied instantly, risky high-value ones sent to an auditor; savings of R$ 1.1 MM from automatic approvals and R$ 1.3 MM from procedures flagged for denial.